Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Human Genetics|May 1, 1992
Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvementD R Jacobson, D E McFarlin, I Kane, et al.Immuno-Oncology Technology|January 12, 2024
Engineering approaches for innate immune-mediated tumor microenvironment remodelingG I Kane, C F Lusi, M L Brassil, et al.Journal of Psychiatric and Mental Health Nursing|May 5, 2011
Medication-taking behaviours in young adults with schizophrenia: a pilot studyH Lee, I Kane, S M Sereika, et al.Trends in Immunology|August 27, 2024
Nanocarrier design for pathogen-inspired innate immune agonist deliveryGriffin I Kane, Meghan L Brassil, Miranda B Diaz-Infante, et al.Journal of Cell Science|April 9, 2020
HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevanceYaya Wang, Diana Argiles-Castillo, Emma I Kane, et al.EMBO Reports|October 23, 2025
Characterization of meiotic axis proteins in the model brown alga EctocarpusEmma I Kane, Lioba S Trefs, Lena Eckert, et al.Research Evaluation|October 17, 2022
Evaluating the Revised National Institutes of Health Clinical Trial Definition Impact on Recruitment ProgressEugene I Kane, Gail L Daumit, Kevin M Fain, et al.Contemporary Clinical Trials|February 25, 2021
Potential benefits and burdens of National Institutes of Health and National Institute of Mental Health clinical trial policiesEugene I Kane, Gail L Daumit, Kevin M Fain, et al.Archives of Physiology and Biochemistry|January 1, 1996
Methodological factors affecting esophageal clearanceI Kane, M Bouchoucha, A A Moukarzel, et al.Contemporary Clinical Trials|February 4, 2021
National Institute of Mental Health Recruitment Monitoring Policy and Clinical Trial ImpactEugene I Kane, Gail L Daumit, Kevin M Fain, et al.Pageof 4